| Clay Siegall, Ph.D. | President, Chief Executive Officer and Chairman of the Board | FY2024 | |
| Robert Lechleider, M.D. | Chief Medical Officer | FY2023 | |
| Max Rosett | Chief Financial Officer | Not disclosed | — |
3 executives
Named executives and their total pay come from the Summary Compensation Table of the latest proxy statement.